Exhibit 99.1

Helius Medical Technologies, Inc.

Unaudited Condensed Interim Consolidated Balance Sheet

The unaudited balance sheet has been filed in order to show compliance with the Nasdaq requirement that the Company maintain a minimum stockholders' equity of $2.5 million for continued listing. The unaudited balance sheet presents the Company’s balance sheet as June 17, 2025 and gives effect to the Company’s public offering that closed on June 6, 2025, as adjusted for the cashless exercise of all warrants issued in the offering.

The Company’s independent registered public accounting firm has not conducted an audit or review of, and does not express an opinion or any other form of assurance with respect to, the balance sheet set forth below. It is possible that the Company or its independent registered public accounting firm may identify items that require the Company to make adjustments to the balance sheet set forth below.

(in thousands, except share data)

June 17, 2025

ASSETS

  

Current assets

  

Cash and cash equivalents

$

6,414

Other receivables

 

84

Inventory, net

 

1,143

Prepaid expenses and other current assets

 

512

Total current assets

 

8,153

Property and equipment, net

 

93

Total assets

$

8,246

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current liabilities

 

  

Accounts payable

$

858

Accrued and other current liabilities

 

712

Current portion of deferred revenue

 

42

Total current liabilities

 

1,612

Deferred revenue, net of current portion

 

66

Derivative liability

7

Total liabilities

 

1,685

Stockholders' equity

 

  

Class A common stock, $0.001 par value; 800,000,000 shares authorized; 34,913,081 shares issued and outstanding as of June 17, 2025

 

35

Additional paid-in capital

 

184,939

Accumulated deficit

 

(178,043)

Accumulated other comprehensive loss

 

(370)

Total stockholders' equity

 

6,561

Total liabilities and stockholders' equity

$

8,246